Patten Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-95	Closed	-$16K	–	647
2018 Q3	$16K	Hold	95	–	–	0.01%	454
2018 Q2	$12K	Buy	+95	New	+$12K	﹤0.01%	460